80 FR 72078 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 222 (November 18, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 222 (November 18, 2015)
| Page Range | 72078-72078 | |
| FR Document | 2015-29380 |
[Federal Register Volume 80, Number 222 (Wednesday, November 18, 2015)] [Notices] [Page 72078] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-29380] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Innovation for HIV Vaccine Discovery (R01). Date: December 10-11, 2015. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3G61, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Jane K. Battles, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room # 3F30B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20852-9823, (240) 669-5029, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: November 12, 2015. Natasha Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015-29380 Filed 11-17-15; 8:45 am] BILLING CODE 4140-01-P
![72078 Federal Register / Vol. 80, No. 222 / Wednesday, November 18, 2015 / Notices
Control and Population Sciences, 9609 precision medicine in cancer treatment Non-respondents will be invited to
Medical Center Drive, 3E438, MSC among medical oncologists in the U.S. complete a follow-back survey to share
9764, Rockville, MD, 20850 or call non- This is a nationally representative their reasons for not participating. The
toll-free number 240–276–6806 or Email survey designed to assess oncologists’ study findings will inform NCI of
your request, including your address to: current and potential use of genomic relevant issues and concerns relating to
janet.demoor@nih.gov. Formal requests testing, to inform the development of the application of precision medicine to
for additional plans and instruments interventions to facilitate optimal use of current and future cancer treatment
must be requested in writing. genomic testing and to improve patient- patterns and practice. This information
Comment Due Date: Comments physician discussions of the risks, will also inform the development of
regarding this information collection are possible benefits, and uncertainties new funding initiatives to optimize the
best assured of having their full effect if surrounding the use of these tests. use of precision medicine in cancer
received within 60 days of the date of Current knowledge of this topic is treatment. Additionally, information
this publication. limited as there are no nationally- collected as part of this survey will be
Proposed Collection: The National representative studies on this topic to used to develop physician educational
Physician Survey of Precision Medicine date. There are only two non-federal materials to address barriers to precision
in Cancer Treatment 0925–NEW, studies two that have examined medicine in cancer care delivery.
National Cancer Institute (NCI), physicians’ knowledge and attitudes OMB approval is requested for 2
National Institutes of Health (NIH). regarding somatic genetic and genomic years. There are no costs to respondents
Need and Use of Information testing. The survey will be administered other than their time. The total
Collection: The purpose of this study is by mail and web to approximately 1,630 estimated annualized burden hours are
to investigate the current practice of oncology physicians across the U.S. 261.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total annual
Form name Type of respondent responses per
respondents response burden hour
respondent (in hours)
Precision Medicine Survey—Pilot Oncology Physicians ........................ 175 1 20/60 58
Study.
Precision Medicine Survey—Full Oncology Physicians ........................ 600 1 20/60 200
Study.
Follow-back Survey ........................... Oncology Physicians ........................ 40 1 5/60 3
Dated: October 28, 2015. Name of Committee: National Institute of DEPARTMENT OF HEALTH AND
Karla Bailey, Allergy and Infectious Diseases Special HUMAN SERVICES
Emphasis Panel; Innovation for HIV Vaccine
Project Clearance Liaison, NCI, NIH.
Discovery (R01). National Institutes of Health
[FR Doc. 2015–29382 Filed 11–17–15; 8:45 am]
Date: December 10–11, 2015.
BILLING CODE 4140–01–P Time: 11:00 a.m. to 5:00 p.m. National Institute on Drug Abuse
Agenda: To review and evaluate grant Amended; Notice of Meeting
applications.
DEPARTMENT OF HEALTH AND Place: National Institutes of Health, Room Notice is hereby given of a change in
HUMAN SERVICES 3G61, 5601 Fishers Lane, Rockville, MD the meeting of the National Institute on
20892 (Telephone Conference Call). Drug Abuse Special Emphasis Panel,
National Institutes of Health Contact Person: Jane K. Battles, Ph.D., November 13, 2015, 01:00 p.m. to
Scientific Review Officer, Scientific Review November 13, 2015, 05:00 p.m.,
National Institute of Allergy and Program, Division of Extramural Activities,
Infectious Diseases; Notice of Closed National Institutes of Health,
Room # 3F30B, National Institutes of Health/
Meeting Neuroscience Center, 6001 Executive
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20852–9823, (240) 669–5029,
Boulevard, Rockville, MD, 20852 which
Pursuant to section 10(d) of the battlesja@mail.nih.gov. was published in the Federal Register
Federal Advisory Committee Act, as on October 22, 2015, 80 FR 64428.
(Catalogue of Federal Domestic Assistance
amended (5 U.S.C. App.), notice is The date of the meeting was changed
Program Nos. 93.855, Allergy, Immunology,
hereby given of the following meeting. to December 1, 2015. The meeting is
and Transplantation Research; 93.856,
The meeting will be closed to the Microbiology and Infectious Diseases closed to the public.
public in accordance with the Research, National Institutes of Health, HHS) Dated: November 12, 2015.
provisions set forth in sections
Dated: November 12, 2015. Natasha Copeland,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and Natasha Copeland, Program Analyst, Office of Federal Advisory
asabaliauskas on DSK5VPTVN1PROD with NOTICES
the discussions could disclose Program Analyst, Office of Federal Advisory Committee Policy.
confidential trade secrets or commercial Committee Policy. [FR Doc. 2015–29379 Filed 11–17–15; 8:45 am]
property such as patentable material, [FR Doc. 2015–29380 Filed 11–17–15; 8:45 am] BILLING CODE 4140–01–P
and personal information concerning BILLING CODE 4140–01–P
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014 18:50 Nov 17, 2015 Jkt 238001 PO 00000 Frm 00039 Fmt 4703 Sfmt 9990 E:\FR\FM\18NON1.SGM 18NON1](https://thefederalregister.org/doc/80_FR_72300/page/1.svg)
Document Created: 2018-03-01 11:20:26
Document Modified: 2018-03-01 11:20:26
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | December 10-11, 2015. | |
| FR Citation | 80 FR 72078 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR